Certified by Founder Lodge
Actithera
Norway - Oslo
START UP
1 Disclosed Funding Rounds $75,500,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 09 ,2025 | Series A | $75,500,000 |
Bioqube Ventures
4BIO Capital
Surveyor Capital
Hadean Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Jupid | $840,000 | (May 1, 2026)
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
